When a strained relationship with another lab left this sponsor feeling deprioritized and lacking confidence during pre-clinical analysis, they knew they needed to place their upcoming clinical phase samples with a partner they could trust.
Program risk came from:
- Poor, infrequent communication
- Lack of urgency
- Clear deprioritization of the program
- Lack of trust in the prior lab’s ability to support the program effectively
Download the case study to learn how Aliri’s Clinical Analysis and Precision Execution (APEX) Process provided a white-glove experience that alleviated this sponsor’s concerns with transparent communication and seamless method transfers.